Skip to main content

Clyype

AM-Adjacent EquipmentGirona, SpainFounded 2020· One of 217 AM-Adjacent Equipment companies tracked by AMPulse

Girona health-technology company, formerly Werlax Invest SL and then Medtech Catalonia SL, that develops and sells Clyype, a powered air-purifying respirator with a helmet and hood.

CEO / Founder
Jordi Bellvehí Muñoz
Team Size
1-10
Stage
Active
Total Funding
$5.5M
Latest Round
Venture Round
Key Investors
ICF (Institut Català de Finances); undisclosed private investors

Technology & Products

Key Products

Clyype powered air-purifying respirator with helmet and hood. Starter kits RHK100/102 (reprocessable hood) and SHK100/102 (single-use hood), helmet CHZ100, inhalation filter IFZ100, exhalation filters EFZ100, battery pack and a washing bag. The company states 99.8% aerosol filtration at TH3 level. The EU declaration of 17 June 2026 cites EN 12941 and declares it Category III PPE and a Class I medical device under MDR 2017/745.

Technical position · AMPulse analysis

Bidirectional filtration in a helmet-hood PAPR, with EU type-examination by AITEX (notified body 0161) under the PPE Regulation and a Class I MDR declaration for filtration of exhaled air. Patent PCT/ES2022/070104 covers the air-filtration device. The company says the design was developed with healthcare professionals.

Differentiation

Value Proposition

A tubeless powered respirator that filters particles and aerosols in inhaled air and filters exhaled air, with a wide visor and both a washable hood and a single-use hood, so the wearer does not need a separate mask.

How They Differentiate

Clyype is sold as a hose-free helmet and hood with separate inhalation and exhalation filters, a non-fogging visor and a reprocessable hood, for wearer protection and source control. 3M Versaflo TH3 hoods are used with a belt-mounted blower and breathing tube. MAXAIR CAPR is a hospital helmet PAPR with outward particulate reduction. CleanSpace HALO is a lightweight hose-free PAPR sold into healthcare, commonly with a half mask rather than a full hood.

Market & Competition

Target Customers

Hospitals and healthcare centres, clean rooms, veterinary clinics and livestock operations, laboratories, dentistry, and emergency medical services.

Industry Verticals

Healthcare; clean rooms; veterinary and livestock; laboratories; dentistry; emergency medical services

Competitors

3M (Versaflo); MAXAIR Systems; CleanSpace

Growth & Milestones

Growth Metrics

Informa lists a micro-enterprise, sales under €300,000, and 2 employees in 2024. LinkedIn lists 2-10 employees. Expansión on 16 October 2025 reported company forecasts of about €300,000 revenue in 2025 and €3.5 million in 2026. Nominal share capital was €60,000 after the April 2026 increase.

Major Milestones

16 September 2020: incorporated as Werlax Invest SL. 25 February 2022: PCT application for the air-filtration device. December 2024: product presented as ready for sale; about 50 investors, 80% from Girona. May 2025: commercial sales started. 5 June 2025: company said it closed a €1.7 million round, taking equity raised to €3.7 million. 23 June 2025: renamed Medtech Catalonia SL and moved to Carrer Santa Eugènia 42, Girona Hub. 31 July 2025: €300,000 ICF Girona Fons d'Innovació loan. October 2025: entered BME Entorno Pre Mercado; €700,000 of a €1 million round reported captured; exclusive hospital distribution signed for Saudi Arabia. 29 January 2026: shareholders approved transformation to a public limited company. 1 April 2026: transformation to Medtech Catalonia SA registered. 17 June 2026: Jordi Bellvehí signed the EU declaration of conformity as CEO. May 2026: reported sales to hospitals in Barcelona, Ceuta and Zaragoza.

Notable Customers

Hospital Clínic de Barcelona; a hospital in Ceuta, described as a repeat buyer; a hospital in Zaragoza. A centre in Rotterdam was in process as of May 2026. Stated by Jordi Bellvehí to Diari de Girona.

Funding rounds

  • Venture Round€700KLead: Undisclosed · Source
  • Debt€300KLead: ICF (Institut Català de Finances) · Source
  • Venture Round€1.7MLead: Undisclosed · Source